Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
Description
The National Center for Advancing Translational Sciences, along with other NIH Institutes, plans to announce a funding opportunity to support research on "undruggable" target classes in challenging human diseases. The goal is to encourage innovative approaches to modulate targets that can't be addressed by existing therapies, leading to new methods or agents selective for these targets. The research should serve as a proof of concept and potentially be expanded to broader studies. "Undruggab…
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method …
Source
Grant ID
PAR-25-442
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- County governments
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Private institutions of higher education
- Small businesses
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- Public housing authorities/Indian housing authorities
- For profit organizations other than small businesses
Awards & Funding
Total Funding
$1M
Funding Amount
Discretionary
Links
Similar opportunities
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Forecast for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
Department of Health and Human Services
- Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
Department of Health and Human Services
- NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Department of Health and Human Services